Department of Medicine and the Stanford Prevention Research Center, Stanford University, Stanford, CA, USA.
Am J Psychiatry. 2013 Mar;170(3):324-33. doi: 10.1176/appi.ajp.2012.12050599.
Schizophrenia is associated with premature mortality, but the specific causes and pathways are unclear. The authors used outpatient and inpatient data for a national population to examine the association between schizophrenia and mortality and comorbidities.
This was a national cohort study of 6,097,834 Swedish adults, including 8,277 with schizophrenia, followed for 7 years (2003-2009) for mortality and comorbidities diagnosed in any outpatient or inpatient setting nationwide.
On average, men with schizophrenia died 15 years earlier, and women 12 years earlier, than the rest of the population, and this was not accounted for by unnatural deaths. The leading causes were ischemic heart disease and cancer. Despite having twice as many health care system contacts, schizophrenia patients had no increased risk of nonfatal ischemic heart disease or cancer diagnoses, but they had an elevated mortality from ischemic heart disease (adjusted hazard ratio for women, 3.33 [95% CI=2.73-4.05]; for men, 2.20 [95% CI=1.83-2.65]) and cancer (adjusted hazard ratio for women, 1.71 [95% CI=1.38-2.10; for men, 1.44 [95% CI=1.15-1.80]). Among all people who died from ischemic heart disease or cancer, schizophrenia patients were less likely than others to have been diagnosed previously with these conditions (for ischemic heart disease, 26.3% compared with 43.7%; for cancer, 73.9% compared with 82.3%). The association between schizophrenia and mortality was stronger among women and the employed. Lack of antipsychotic treatment was also associated with elevated mortality.
Schizophrenia patients had markedly premature mortality, and the leading causes were ischemic heart disease and cancer, which appeared to be underdiagnosed. Preventive interventions should prioritize primary health care tailored to this population, including more effective risk modification and screening for cardiovascular disease and cancer.
精神分裂症与过早死亡有关,但具体的病因和途径尚不清楚。作者利用全国范围内的门诊和住院数据,研究了精神分裂症与死亡率和合并症之间的关系。
这是一项对 6097834 名瑞典成年人的全国性队列研究,其中包括 8277 名精神分裂症患者,随访 7 年(2003-2009 年),观察全国范围内任何门诊或住院环境下的死亡率和合并症诊断。
平均而言,男性精神分裂症患者比普通人群早死亡 15 年,女性早死亡 12 年,这并不是非自然死亡造成的。主要死因是缺血性心脏病和癌症。尽管精神分裂症患者的医疗保健系统接触次数是普通人群的两倍,但他们没有增加非致命性缺血性心脏病或癌症诊断的风险,但他们死于缺血性心脏病的风险增加(女性调整后的危险比为 3.33[95%CI=2.73-4.05];男性为 2.20[95%CI=1.83-2.65])和癌症(女性调整后的危险比为 1.71[95%CI=1.38-2.10;男性为 1.44[95%CI=1.15-1.80])。在所有死于缺血性心脏病或癌症的人中,精神分裂症患者以前被诊断出患有这些疾病的可能性低于其他人(缺血性心脏病为 26.3%,而癌症为 73.9%)。精神分裂症与死亡率之间的关联在女性和就业人群中更强。缺乏抗精神病药物治疗也与死亡率升高有关。
精神分裂症患者的死亡率明显提前,主要死因是缺血性心脏病和癌症,这些疾病似乎被漏诊了。预防干预措施应优先考虑针对这一人群的初级保健,包括更有效的心血管疾病和癌症的风险修正和筛查。